Newsroom

Sorted by: Latest

-

Veradigm Receives KLAS 2026 Points of Light Award for Embedding SDOH Data in Provider EHR Workflows

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that it has been recognized by KLAS in the 2026 Points of Light Award program for a collaborative initiative that embedded payer-derived social determinants of health (SDOH) data directly into provider EHR workflows. The recognition, awarded as part of the KLAS K2 Collaborative, highlights a multi-organization effort involving Veradigm, a nat...
-

Seacoast Reports First Quarter 2026 Results

STUART, Fla.--(BUSINESS WIRE)--Seacoast Banking Corporation of Florida ("Seacoast" or the "Company") (NASDAQ: SBCF) today reported unaudited results of operations and other financial information for the first quarter of 2026. First Quarter 2026 Highlights Net income of $31.9 million included a $39.5 million loss from a strategic repositioning of available-for-sale securities executed in January 2026. This action involved selling approximately $277.0 million in low-yielding securities and reinve...
-

CareDx Announces First Quarter 2026 Financial Results

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights Revenue of $118 million, an increase of 39% year-over-year Testing services revenue of $91 m...
-

Arch Capital Group Ltd. Reports 2026 First Quarter Results

PEMBROKE, Bermuda--(BUSINESS WIRE)--Arch Capital Group Ltd. (NASDAQ: ACGL; “Arch,” “our” or “the Company”) announces its 2026 first quarter results. The results included: Net income available to Arch common shareholders of $1.0 billion, or $2.88 per share, representing a 17.8% annualized net income return on average common equity, compared to net income available to Arch common shareholders of $564 million, or $1.48 per share, for the 2025 first quarter. After-tax operating income available to...
-

Caesars Entertainment, Inc. Reports First Quarter 2026 Results

LAS VEGAS & RENO, Nev.--(BUSINESS WIRE)--Caesars Entertainment, Inc., (NASDAQ: CZR) (“Caesars,” “CZR,” “CEI” or the “Company”) today reported operating results for the first quarter ended March 31, 2026. First Quarter 2026 and Recent Highlights: GAAP net revenues of $2.9 billion versus $2.8 billion for the comparable prior-year period. GAAP net loss of $98 million compared to a net loss of $115 million for the comparable prior-year period. Consolidated Adjusted EBITDA of $887 million versus $88...
-

Magnachip Reports Results for First Quarter 2026

SEOUL, South Korea--(BUSINESS WIRE)--Magnachip Semiconductor Corporation (NYSE: MX) (“Magnachip” or the “Company”) today announced financial results for the first quarter 2026. Camillo Martino, Magnachip’s CEO said, “We delivered better-than-seasonal revenue growth in the quarter, reflecting both solid execution and also the impact of the previously communicated inventory and channel actions. We are comfortable with our progress toward our multi-year transformation, and we are showing some good...
-

CUPE's Extendicare Central Table Receives Overwhelming Mandate for Job Action if a Deal is not Reached

MARKHAM, ON.--(BUSINESS WIRE)--CUPE’s Extendicare Central Bargaining table is holding strategic planning meetings in Markham this week, one month after negotiations ended with Extendicare. The eight CUPE locals from across Ontario represent over 1100 Long-Term Care workers at various Extendicare facilities in the province. This central bargaining table sets the pattern for collective bargaining in the sector. Extendicare and the Central Table broke off bargaining on April 1st with many items ou...
-

ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP announces that a securities class action has been filed against Aldeyra Therapeutics, Inc. (NASDAQ: ALDX). YOU MAY BE AFFECTED IF YOU: Purchased ALDX stock between November 3, 2023 and March 16, 2026 Lost money on your Aldeyra investment Find out if you qualify to recover losses from this securities action or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500. Shares of Aldeyra collapsed 70.7%, losing $2.99 per share, a...
-

PINS Investor Alert: Pinterest Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misleading Institutional Shareholders: Levi & Korsinsky

NEW YORK--(BUSINESS WIRE)--Institutional investors holding positions in Pinterest, Inc. (NYSE: PINS) during the period from February 7, 2025 through February 12, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.PINS shares suffered a cumulative decline of $12.77 per share across three corrective disclosures, falling...
-

VITL Investor Alert: Vital Farms, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Filed Inadequate Disclosures: Levi & Korsinsky

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP examines the adequacy of Vital Farms, Inc.'s (NASDAQ: VITL) risk disclosures in connection with a securities class action filed on behalf of shareholders who purchased securities between May 8, 2025 and February 26, 2026. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500. Vital Farms shares fell $2.68 per share, a 10.8% decline, closing at $22.11 on February 26, 202...